{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T11:02:53Z","timestamp":1793012573609,"version":"4.5.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T00:00:00Z","timestamp":1718409600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Government of Japan Ministry of Health Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.nbd.2024.106571","type":"journal-article","created":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T06:55:38Z","timestamp":1718693738000},"page":"106571","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Clinical characteristics and pathophysiological properties of newly discovered LRRK2 variants associated with Parkinson's disease"],"prefix":"10.1016","volume":"199","author":[{"given":"Toshiki","family":"Tezuka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayu","family":"Ishiguro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehoto","family":"Osogaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kahori","family":"Shiba-Fukushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanzhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyo","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taro","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Kaida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Funayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenya","family":"Nishioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihisa","family":"Kumazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyasu","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Tsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Murayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzuru","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobutaka","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2024.106571_bb0005","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/mds.29449","article-title":"Patterns of TDP-43 deposition in brains with LRRK2 G2019S mutations","volume":"38","author":"Agin-Liebes","year":"2023","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2024.106571_bb0010","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1002\/mds.28191","article-title":"Evaluating the role of SNCA, LRRK2, and GBA in Chinese patients with early-onset Parkinson\u2019s disease","volume":"35","author":"Chen","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2024.106571_bb0015","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1042\/BST20120165","article-title":"Cellular effects of LRRK2 mutations","volume":"40","author":"Cookson","year":"2012","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.nbd.2024.106571_bb0020","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/mds.22096","article-title":"Clinical and pathological characteristics of patients with leucine-rich repeat kinase-2 mutations","volume":"24","author":"Covy","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2024.106571_bb0025","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1073\/pnas.0709098105","article-title":"Structure of the ROC domain from the Parkinson\u2019s disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase","volume":"105","author":"Deng","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.nbd.2024.106571_bb0030","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/s41586-020-2673-2","article-title":"Structure of LRRK2 in Parkinson\u2019s disease and model for microtubule interaction","volume":"588","author":"Deniston","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2024.106571_bb0035","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aar5429","article-title":"LRRK2 activation in idiopathic Parkinson\u2019s disease","volume":"10","author":"Di Maio","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.nbd.2024.106571_bb0040","series-title":"ACGS Best Practice Guidelines for Variant Classification 2017","author":"Ellard","year":"2017"},{"key":"10.1016\/j.nbd.2024.106571_bb0045","first-page":"266","article-title":"Diversity of pathological features other than Lewy bodies in familial Parkinson\u2019s disease due to SNCA mutations","volume":"2","author":"Fujishiro","year":"2013","journal-title":"Am. J. Neurodegener. Dis."},{"key":"10.1016\/j.nbd.2024.106571_bb0050","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/ana.20484","article-title":"An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family","volume":"57","author":"Funayama","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2024.106571_bb0055","first-page":"415","article-title":"A common LRRK2 mutation in idiopathic Parkinson\u2019s disease","volume":"365","author":"Gilks","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2024.106571_bb0060","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/hmg\/ddi439","article-title":"The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity","volume":"15","author":"Gloeckner","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2024.106571_bb0065","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.1038\/ncomms6245","article-title":"Increasing microtubule acetylation rescues axonal transport and locomotor deficits caused by LRRK2 roc-COR domain mutations","volume":"5","author":"Godena","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2024.106571_bb0070","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1038\/emboj.2008.150","article-title":"Structure of the roc-COR domain tandem of C. Tepidum, a prokaryotic homologue of the human LRRK2 Parkinson kinase","volume":"27","author":"Gotthardt","year":"2008","journal-title":"EMBO J."},{"key":"10.1016\/j.nbd.2024.106571_bb0075","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s40478-019-0836-x","article-title":"Alzheimer\u2019s disease tau is a prominent pathology in LRRK2 Parkinson\u2019s disease","volume":"7","author":"Henderson","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.nbd.2024.106571_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005503","article-title":"The Parkinson\u2019s disease-associated protein kinase LRRK2 modulates notch signaling through the endosomal pathway","volume":"11","author":"Imai","year":"2015","journal-title":"PLoS Genet."},{"key":"10.1016\/j.nbd.2024.106571_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105476","article-title":"Parkinson disease-associated Leucine-rich repeat kinase regulates UNC-104-dependent axonal transport of Arl8-positive vesicles in Drosophila","volume":"25","author":"Inoshita","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.nbd.2024.106571_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/biom13010178","article-title":"Is glial dysfunction the key pathogenesis of LRRK2-linked Parkinson\u2019s disease?","volume":"13","author":"Iseki","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.nbd.2024.106571_bb0095","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2024.106571_bb0100","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1001\/jamaneurol.2014.2704","article-title":"Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease","volume":"72","author":"Kalia","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.nbd.2024.106571_bb0105","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1042\/BCJ20220161","article-title":"Impact of 100 LRRK2 variants linked to Parkinson\u2019s disease on kinase activity and microtubule binding","volume":"479","author":"Kalogeropulou","year":"2022","journal-title":"Biochem. J."},{"key":"10.1016\/j.nbd.2024.106571_bb0110","doi-asserted-by":"crossref","first-page":"10963","DOI":"10.1021\/bi9011379","article-title":"Identification of the autophosphorylation sites of LRRK2","volume":"48","author":"Kamikawaji","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.nbd.2024.106571_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030834","article-title":"LRRK2 phosphorylates tubulin-associated tau but not the free molecule: LRRK2-mediated regulation of the tau-tubulin association and neurite outgrowth","volume":"7","author":"Kawakami","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2024.106571_bb0120","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/hmg\/ddr526","article-title":"LRRK2 Parkinson disease mutations enhance its microtubule association","volume":"21","author":"Kett","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2024.106571_bb0125","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/33416","article-title":"Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism","volume":"392","author":"Kitada","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2024.106571_bb0130","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-023-00622-7","article-title":"Neuropathology of incidental Lewy body & prodromal Parkinson\u2019s disease","volume":"18","author":"Koeglsperger","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2024.106571_bb0135","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/neup.12144","article-title":"Simplification of the modified Gallyas method","volume":"35","author":"Kuninaka","year":"2015","journal-title":"Neuropathology"},{"key":"10.1016\/j.nbd.2024.106571_bb0140","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1042\/BST20120113","article-title":"The synaptic function of LRRK2","volume":"40","author":"Lee","year":"2012","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.nbd.2024.106571_bb0145","doi-asserted-by":"crossref","first-page":"150.e5","DOI":"10.1016\/j.neurobiolaging.2019.12.023","article-title":"Whole-exome sequencing in early-onset Parkinson\u2019s disease among ethnic Chinese","volume":"90","author":"Li","year":"2020","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2024.106571_bb0150","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/s10038-020-0772-4","article-title":"Clinical characterization of patients with leucine-rich repeat kinase 2 genetic variants in Japan","volume":"65","author":"Li","year":"2020","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.nbd.2024.106571_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2013.04.011","article-title":"TDP-43 pathology in a patient carrying G2019S LRRK2 mutation and a novel p.Q124E MAPT","volume":"34","author":"Ling","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2024.106571_bb0160","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature13127","article-title":"Guidelines for investigating causality of sequence variants in human disease","volume":"508","author":"MacArthur","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2024.106571_bb0165","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/mds.22677","article-title":"Neuropathology of Parkinson\u2019s disease with the R1441G mutation in LRRK2","volume":"24","author":"Marti-Masso","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2024.106571_bb0170","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.cell.2014.01.064","article-title":"Ribosomal protein s15 phosphorylation mediates LRRK2 neurodegeneration in Parkinson's disease","volume":"157","author":"Martin","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2024.106571_bb0175","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.parkreldis.2020.05.035","article-title":"A novel rare variant of LRRK2 associated with familial Parkinson\u2019s disease: p.R1501W","volume":"76","author":"Masuzugawa","year":"2020","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2024.106571_bb0180","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2024.106571_bb0185","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/978-3-319-49969-7_4","article-title":"Understanding the GTPase activity of LRRK2: regulation, function, and neurotoxicity","volume":"14","author":"Nguyen","year":"2017","journal-title":"Adv. Neurobiol."},{"key":"10.1016\/j.nbd.2024.106571_bb0190","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22073708","article-title":"A novel LRRK2 variant p.G2294R in the WD40 domain identified in familial Parkinson\u2019s disease affects LRRK2 protein levels","volume":"22","author":"Ogata","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.nbd.2024.106571_bb0195","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.neuron.2004.10.023","article-title":"Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease","volume":"44","author":"Pais\u00e1n-Ru\u00edz","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2024.106571_bb0200","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2024.106571_bb0205","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"10.1016\/j.nbd.2024.106571_bb0210","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.parkreldis.2021.09.009","article-title":"First Japanese autopsy case showing LRRK2 mutation G2019S and TDP-43 proteinopathy","volume":"91","author":"Sakuwa","year":"2021","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2024.106571_bb0215","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1042\/BST20120117","article-title":"LRRK2 and vesicle trafficking","volume":"40","author":"Sanna","year":"2012","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.nbd.2024.106571_bb0220","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/mds.27193","article-title":"Neuropathology of genetic synucleinopathies with parkinsonism: review of the literature","volume":"32","author":"Schneider","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2024.106571_bb0225","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/jhg.2011.79","article-title":"Comprehensive mutational analysis of LRRK2 reveals variants supporting association with autosomal dominant Parkinson\u2019s disease","volume":"56","author":"Seki","year":"2011","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.nbd.2024.106571_bb0230","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004485","article-title":"Ser1292 autophosphorylation is an indicator of LRRK2 kinase activity and contributes to the cellular effects of PD mutations","volume":"4","author":"Sheng","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.nbd.2024.106571_bb0235","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/s41594-022-00863-y","article-title":"Structural basis for Parkinson\u2019s disease-linked LRRK2\u2019s binding to microtubules","volume":"29","author":"Snead","year":"2022","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.nbd.2024.106571_bb0240","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.12813","article-title":"Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases","volume":"5","author":"Steger","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.nbd.2024.106571_bb0245","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.31012","article-title":"Systematic proteomic analysis of LRRK2-mediated Rab GTPase phosphorylation establishes a connection to ciliogenesis","volume":"6","author":"Steger","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.nbd.2024.106571_bb0250","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s40478-018-0617-y","article-title":"Isolated nigral degeneration without pathological protein aggregation in autopsied brains with LRRK2 p.R1441H homozygous and heterozygous mutations","volume":"6","author":"Takanashi","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.nbd.2024.106571_bb0255","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00401-020-02233-8","article-title":"Lewy pathology of the esophagus correlates with the progression of Lewy body disease: a Japanese cohort study of autopsy cases","volume":"141","author":"Tanei","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2024.106571_bb0260","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41531-022-00367-y","article-title":"Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson's disease","volume":"8","author":"Tezuka","year":"2022","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.nbd.2024.106571_bb0265","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.parkreldis.2012.03.024","article-title":"LRRK2 I2020T mutation is associated with tau pathology","volume":"18","author":"Ujiie","year":"2012","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2024.106571_bb0270","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/PL00007400","article-title":"NACP\/alpha-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson's disease brains","volume":"99","author":"Wakabayashi","year":"2000","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2024.106571_bb0275","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.cell.2020.08.004","article-title":"The in situ structure of Parkinson\u2019s disease-linked LRRK2","volume":"182","author":"Watanabe","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2024.106571_bb0280","doi-asserted-by":"crossref","first-page":"16842","DOI":"10.1073\/pnas.0507360102","article-title":"Parkinson\u2019s disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity","volume":"102","author":"West","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.nbd.2024.106571_bb0285","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1212\/01.WNL.0000125015.06989.DB","article-title":"Autosomal dominant parkinsonism associated with variable synuclein and tau pathology","volume":"62","author":"Wszolek","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2024.106571_bb0290","doi-asserted-by":"crossref","first-page":"5907","DOI":"10.1074\/jbc.RA119.007631","article-title":"Parkinson\u2019s disease-associated mutations in the GTPase domain of LRRK2 impair its nucleotide-dependent conformational dynamics","volume":"294","author":"Wu","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2024.106571_bb0295","article-title":"A revised 1.6 \u00c5 structure of the GTPase domain of the Parkinson\u2019s disease-associated protein LRRK2 provides insights into mechanisms","author":"Wu","year":"2019","journal-title":"bioRxiv"},{"key":"10.1016\/j.nbd.2024.106571_bb0300","doi-asserted-by":"crossref","first-page":"187.e5","DOI":"10.1016\/j.neurobiolaging.2018.06.036","article-title":"Genetic analysis of LRRK2 in Parkinson\u2019s disease in Han Chinese population","volume":"72","author":"Zhang","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2024.106571_bb0305","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1093\/brain\/awaa167","article-title":"The role of genetics in Parkinson's disease: a large cohort study in Chinese mainland population","volume":"143","author":"Zhao","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2024.106571_bb0310","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1126\/science.adi9926","article-title":"Rab29-dependent asymmetrical activation of leucine-rich repeat kinase 2","volume":"382","author":"Zhu","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.nbd.2024.106571_bb0315","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","article-title":"Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology","volume":"44","author":"Zimprich","year":"2004","journal-title":"Neuron"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996124001712?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996124001712?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T12:27:51Z","timestamp":1738585671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996124001712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":63,"alternative-id":["S0969996124001712"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2024.106571","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical characteristics and pathophysiological properties of newly discovered LRRK2 variants associated with Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2024.106571","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106571"}}